CNS5:Diffuse hemispheric glioma, H3 G34-mutant: Difference between revisions

[unchecked revision][checked revision]
Lynn.Hu (talk | contribs)
Line 1: Line 1:
==NPrimary Author(s)*==
==Primary Author(s)*==


Xiaolin Hu, PhD, Sema4 OpCo Inc.
Xiaolin Hu, PhD, Sema4 OpCo Inc.
Line 175: Line 175:
==Gene Mutations (SNV/INDEL/Methylation)==
==Gene Mutations (SNV/INDEL/Methylation)==


Put your text here and fill in the table
<br />


{| class="wikitable sortable"
{| class="wikitable sortable"
Line 185: Line 185:
!Notes
!Notes
|-
|-
|H3F3A p.G35R/V
|''H3-3A'' p.G35R/V
|chromosome modification
|chromosome modification
|p.G35R 94%
|p.G35R 94%
Line 206: Line 206:
|
|
|-
|-
|MGMT
|''MGMT''
|promoter methylation
|promoter methylation
|70%-74% of G34-DHG <ref name=":1" /><ref name=":4" />
|70%-74% of G34-DHG <ref name=":1" /><ref name=":4" />
Line 251: Line 251:
*DNA methylation and gene expression profiling can be used to differentiate G34-DHG with other glioma subgroups.
*DNA methylation and gene expression profiling can be used to differentiate G34-DHG with other glioma subgroups.
*''MGMT'' promoter methylation can be assessed by methylation specific polymerase chain reaction analysis (bisulfite treated DNA undergoes real-time PCR)<br />
*''MGMT'' promoter methylation can be assessed by methylation specific polymerase chain reaction analysis (bisulfite treated DNA undergoes real-time PCR)<br />
==Familial Forms==
Put your text here
==Additional Information==
Put your text here
==Links==
Put your text placeholder here (use "Link" icon at top of page)


==References==
==References==